Eximia Research, an integrated clinical trial network, has acquired Integrated Clinical Trial Services (ICTS) and expanded into Iowa, USA.
This move is expected to enhance access to advanced clinical trials and medical solutions across the country.
West Des Moines-based ICTS claims to be the region’s only full-time specialty research clinic, conducting clinical trials in a variety of therapeutic areas.
The clinic focuses on raising awareness of the value of clinical trials among the general public and medical professionals.
He brings over 19 years of clinical research experience to the Eximia network. Kristine Majors, a registered nurse, brings her academic and clinical trial experience to lead the clinic.
Together with her husband, Joe Majors, ICTS has developed into a multidisciplinary center of excellence, contributing to the advancement of new treatments.
With the integration of ICTS into Eximia’s network, the West Des Moines community is expected to have improved access to clinical trials and treatments.
said Ella Grach, CEO of Eximia Research. “The addition of this established and successful site strengthens our ability to bring cutting-edge clinical trials to more communities and reinforces our commitment to expanding access to high-quality clinical research. It will be done.”
“With its experienced leadership and focus on patient care, particularly in pediatrics, metabolic disease, and a wide range of other therapeutic areas, ICTS is a great fit for our growing network.”
This partnership complements Eximia’s presence in the Midwest, including Sundance Clinical Research in St. Louis and other locations in the Mid-Atlantic, Southeast, and Western United States, and will have a positive impact on healthcare in the region. It is expected that.
In August, Eximia Research announced the acquisition of Tidewater Clinical Research, a women’s health and ophthalmology clinical trial company in the Hampton Roads/Eastern Virginia region of the United States.
“Eximia Research Acquires Integrated Clinical Trials Services” was originally created and published by Clinical Trials Arena, a brand owned by GlobalData.
The information on this site is published in good faith and for general information purposes only. It is not intended to constitute advice on which you should rely, and we make no representations or warranties of any kind, express or implied, as to its accuracy or completeness. You should obtain professional or specialist advice before taking, or refraining from, any action on the basis of any content on our site.
